Kalivir Immunotherapeutics Patents – Insights & Stats (Updated 2024)

Kalivir Immunotherapeutics has a total of 71 patents globally, out of which no patent has been granted. Of these 71 patents, more than 92% patents are active. The United States of America is where Kalivir Immunotherapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kalivir Immunotherapeutics.

Kalivir Immunotherapeutics was founded in 2019. The company develops oncolytic vaccinia platform for enhanced intravenous delivery, targeted tumor replication, and spread within the tumor environment. Their system offers tailored transgene programs with proprietary genetic modifications for advanced oncolytic viral immunotherapy.

Do read about some of the most popular patents of Kalivir Immunotherapeutics which have been covered by us in this article and also you can find Kalivir Immunotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kalivir Immunotherapeutics patent portfolio.

How many patents does Kalivir Immunotherapeutics have?

Kalivir Immunotherapeutics has a total of 71 patents globally. These patents belong to 9 unique patent families. Out of 71 patents, 66 patents are active.

How Many Patents did Kalivir Immunotherapeutics File Every Year?

Kalivir Immunotherapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantKalivir Immunotherapeutics Applications FiledKalivir Immunotherapeutics Patents Granted
202313
202218
202118
202014
20193
20185

How many Kalivir Immunotherapeutics patents are Alive/Dead?

Worldwide Patents

Kalivir Immunotherapeutics Patent Portfolio

How Many Patents did Kalivir Immunotherapeutics File in Different Countries?

Kalivir Immunotherapeutics Worldwide Patent Filing

Countries in which Kalivir Immunotherapeutics Filed Patents

CountryPatent
United States Of America12
Australia8
Canada8
Europe7
Hong Kong (S.A.R.)4
South Africa3
Singapore3
Taiwan3
Israel3
New Zealand3
Colombia2
Mexico2
Costa Rica1
Brazil1
Chile1
Dominican Republic1
Viet Nam1
Peru1
Ecuador1
Eurasian Patent Organization1

Where are Research Centers of Kalivir Immunotherapeutics Patents Located?

R&D Centres of Kalivir Immunotherapeutics

What Percentage of Kalivir Immunotherapeutics US Patent Applications Were Granted?

Kalivir Immunotherapeutics (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these no patent has been granted leading to a grant rate of 0%.

Below are the key stats of Kalivir Immunotherapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Kalivir Immunotherapeutics?

Law FirmTotal ApplicationsSuccess Rate
Greenberg Traurig Llp90%

What are Kalivir Immunotherapeutics key innovation segments?

What Technologies are Covered by Kalivir Immunotherapeutics?

The chart below distributes patents filed by Kalivir Immunotherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Kalivir Immunotherapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Kalivir Immunotherapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Kalivir Immunotherapeutics?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.